Phapros Tbk. vs Zyrexindo Mandiri Buana Tbk. — how do they compare? Phapros Tbk. trades at Rp254 (market cap 220.08B, 204.7K 24h volume), while Zyrexindo Mandiri Buana Tbk. trades at Rp129 (market cap 173.33B, 1.04M 24h volume). The key difference: Phapros Tbk. is the larger of the two by market cap, and Zyrexindo Mandiri Buana Tbk. is more actively traded (1.04M versus 204.7K). Which is the better fit depends on your goals.
| PEHA | ZYRX | |
|---|---|---|
Market Cap | 220.08B | 173.33B |
Volume | 204.7K | 1.04M |
Lot | 2.05K | 10.41K |
Turnover | 52.61M | 134.49M |
Average Price | 256.99 | 129.19 |
Value | 52.61M | 134.49M |
Indicative Equilibrium Price | — | 129 |
Indicative Equilibrium Volume | — | 15 |
Trailing returns across standard periods
Latest headlines on both assets
PT Phapros Tbk was established under the name of N.V. Pharmaceutical Processing Industries, in short N.V. Phapros, based on Notarial Deed No 54 of Tan A Sioe dated 21 June 1954, which later became PT Pharmaceutical Processing Industries, in short PT Phapros based on Notarial Deed No.43 of E. Pondaag, replacing R.M. Soerojo, dated 5 September 1995, which finally became PT Phapros based on Notarial Deed No. 48 of Prof. Dr. Liliana Tedjosaputro, S.H., M.H., MM., dated 12 April 2006. The Company’s immediate and ultimate parent entity is PT Rajawali Nusantara Indonesia, incorporatedand domiciled in Indonesia.
Read more on PEHA →PT Zyrexindo Mandiri Buana Tbk (the Company) is a limited liability company established in Indonesia based on Notarial Deed No. 43 of Jimmy Simanungkalit, S.H., on May 14, 1996. The Company commenced its commercial operations in 1996. The majority shareholder of the Company is Timothy Siddik
Read more on ZYRX →